International Edition
Latest News
Health

Acanthamoeba Proteome Reveals New Targets to Treat Keratitis

Acanthamoeba Mitochondria Generate Hydrogen Gas Under Anoxia Single-celled pathogen Acanthamoeba castellanii can generate hydrogen gas under anoxic conditions by completely retooling its energy-producing machinery. Published in Cell, this newly discovered metabolic flexibility helps explain how the organism persists…

Acanthamoeba

Acanthamoeba Mitochondria Generate Hydrogen Gas Under Anoxia

Single-celled pathogen Acanthamoeba castellanii can generate hydrogen gas under anoxic conditions by completely retooling its energy-producing machinery. Published in Cell, this newly discovered metabolic flexibility helps explain how the organism persists in the human cornea to cause sight-threatening keratitis.

Current treatments for these infections remain severely limited. The pathogen frequently retreats into a drug-resistant cyst, while existing therapies are untargeted and toxic to human cells. To uncover new therapeutic vulnerabilities, investigators set out to map the mitochondrial proteins of the organism.

Building AcMitoCarta: Cataloging 381 Unique Proteins

Investigators built a high-confidence inventory of the proteins operating inside Acanthamoeba castellanii mitochondria, a catalog designated as AcMitoCarta. Led by investigators at the Morgridge Institute for Research and the University of Wisconsin School of Medicine and Public Health, alongside the MitoCarta Tree of Life Consortium conceived by researchers from the Broad Institute, Massachusetts General Hospital, Harvard Medical School, and the Howard Hughes Medical Institute, the team utilized mitochondrial immunoprecipitation, density-gradient purification, microscopy, mass spectrometry, and protein-correlation profiling.

The resulting catalog contains 1,122 proteins. This inventory includes 381 without readily identifiable counterparts in human or yeast mitochondria, with just over 300 proteins described as unique when compared with human and yeast models.

Jon Stefely, PhD, a metabolism investigator at the Morgridge Institute for Research and assistant professor of biomolecular chemistry at the University of Wisconsin School of Medicine and Public Health, noted the therapeutic implications of such divergence in the GEN report. “What’s been proven historically is that if you have a target protein in a biochemical pathway that’s completely unique to the microbe, it’s a better target than something that has a homolog in humans,” Stefely said. Compounds directed at microbe-specific pathways carry a lower risk of damaging human cells.

Overhauling Genomic Annotation to Enable Proteome Mapping

Before cataloging the proteins, researchers had to substantially improve the organism’s nuclear genome annotation. Because most mitochondrial proteins are encoded in the nucleus, the team raised the annotation accuracy from roughly 52% to 98% using long-read RNA sequencing and empirical methods.

Stefely compared the unrefined genome to a confusing manuscript. “If you imagine a page of words in a book, it would be like all the words were squished together and in a language that you don’t know,” Stefely told GEN. “You would have to ask, ‘Where are the words? How do I separate one word from the next?’ It’s hard to tease apart.”

Using Blue native PAGE–mass spectrometry for complexome profiling, the research team also resolved 20 macromolecular assemblies within the organelle.

Oxygen Deprivation Triggers Pyruvate-to-Hydrogen Pathway

Proteomic and transcriptomic profiling revealed that oxygen availability extensively rewires the bioenergetic machinery of the amoeba. Under oxygen-rich conditions, the mitochondria rely on aerobic pathways. Under anoxia, however, the organism induces a pyruvate:ferredoxin oxidoreductase-to-hydrogenase pathway.

Researchers demonstrated that Acanthamoeba cells derived from eye infections produce hydrogen gas without oxygen through a mitochondria-localized, oxygen-sensitive hydrogenase. This dynamic shift allows the organism to adapt to changing environments, including the hypoxic niches of the human cornea.

“It’s a big challenge. The lack of readily available diagnostics is a problem, and then even after you finally get to the diagnosis, we don’t have good drugs,” Stefely said, as quoted by GEN. “Our current drugs are untargeted and toxic, and we just need more options for treating these infections.”

Standardized Framework for Testing Amoebal Survival Targets

AcMitoCarta now provides a standardized framework for testing which unusual proteins are essential for amoebal survival, oxygen adaptation, and cyst formation. Stefely plans to examine the targets in focused groups alongside collaborators specializing in mass spectrometry, RNA sequencing, metabolism, structural biology, and imaging, with the long-term goal of annotating functions for all identified targets.

Frequently Asked Questions About Acanthamoeba Keratitis Research

What causes Acanthamoeba keratitis and how common is it?
Acanthamoeba is a free-living, single-celled organism found in water, soil, and air that can infect the cornea and cause sight-threatening keratitis, though disease is rare.

Why are current Acanthamoeba infections difficult to treat?
Current treatments are limited, untargeted, and toxic to human cells, and the pathogen can retreat into a drug-resistant cyst.

What is the significance of the AcMitoCarta catalog?
AcMitoCarta catalogs 1,122 mitochondrial proteins—including 381 without human or yeast counterparts—providing new targets for developing selective therapeutics that avoid damaging human cells.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”